Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Bifidobacterium animalis lactis + Bifidobacterium bifidum + Lacticaseibacillus casei + Lactobacillus acidophilus + Lactococcus lactis + Levilactobacillus brevis + Ligilactobacillus salivarius & Type 2 Diabetes (T2D)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

NCT01765517
revealed that using Bifidobacterium animalis lactis + Bifidobacterium bifidum + Lacticaseibacillus casei + Lactobacillus acidophilus + Lactococcus lactis + Levilactobacillus brevis + Ligilactobacillus salivarius daily for 12/13 weeks significantly improved HOMA‑IR and modestly reduced abdominal adiposity among medication naïve T2DM patients. However, regarding the primary objectives there was no observed difference in Lipopolysaccharides (LPS) levels between the groups (1)

(1) Sabico et al. 2017 J Transl Med 15(1): 249

see also:
[Probiotics (living agents) & Ty…

Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial
Sabico et al. 2017 J Transl Med 15(1): 249

7/1/2026